Combination therapy improves outcomes for advanced triple-negative breast cancer

Published Date: 22 Aug 2025

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Are ultramarathon runners really at increased risk of bowel cancer?

2.

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

3.

ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

4.

Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

5.

No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot